IL118188A - Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug - Google Patents

Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug

Info

Publication number
IL118188A
IL118188A IL11818896A IL11818896A IL118188A IL 118188 A IL118188 A IL 118188A IL 11818896 A IL11818896 A IL 11818896A IL 11818896 A IL11818896 A IL 11818896A IL 118188 A IL118188 A IL 118188A
Authority
IL
Israel
Prior art keywords
plasma
assured
quality
drug
preparation
Prior art date
Application number
IL11818896A
Other languages
English (en)
Other versions
IL118188A0 (en
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3499516&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL118188(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of IL118188A0 publication Critical patent/IL118188A0/xx
Publication of IL118188A publication Critical patent/IL118188A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • G01N2496/05Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
IL11818896A 1995-05-08 1996-05-08 Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug IL118188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0077895A AT406019B (de) 1995-05-08 1995-05-08 Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate

Publications (2)

Publication Number Publication Date
IL118188A0 IL118188A0 (en) 1996-09-12
IL118188A true IL118188A (en) 2000-07-16

Family

ID=3499516

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11818896A IL118188A (en) 1995-05-08 1996-05-08 Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug

Country Status (10)

Country Link
EP (1) EP0769954B2 (xx)
JP (2) JPH10502943A (xx)
AT (2) AT406019B (xx)
CA (1) CA2191475C (xx)
DE (1) DE59610626D1 (xx)
DK (1) DK0769954T4 (xx)
ES (1) ES2203688T5 (xx)
IL (1) IL118188A (xx)
NO (1) NO322186B1 (xx)
WO (1) WO1996035437A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780222A (en) 1995-04-10 1998-07-14 Alpha Therapeutic Corporation Method of PCR testing of pooled blood samples
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
WO1999023249A2 (de) * 1997-11-04 1999-05-14 Roche Diagnostics Gmbh Spezifisches und empfindliches nukleinsäurenachweisverfahren
DE19752898A1 (de) * 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
AT407160B (de) * 1998-06-04 2001-01-25 Immuno Ag Verfahren zur bestimmung von antigenen
SI1151007T1 (sl) 1999-02-12 2006-10-31 Baxter Ag Postopek za pripravo pripravka na osnovi fibrinogena in fibronektina in proteinski sestavki, ki jihlahko dobimo po tem postopku
AT410218B (de) 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
WO2005054275A2 (en) * 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor vii solutions to remove virus
DE102005054206B4 (de) * 2005-11-14 2010-07-15 Roth, Willi, Prof. Dr. Verfahren und Vorrichtung zum automatisierten Bearbeiten von gepoolten Proben
JP2018529332A (ja) * 2015-09-02 2018-10-11 イーピー ミネラルス,エルエルシー 発酵液体の処理に有用な再生された媒体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447984A1 (en) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
WO1992001714A1 (en) 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Non-a non-b hepatitis virus antigen
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 C型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
JPH04300000A (ja) * 1991-03-27 1992-10-23 Teijin Ltd 核酸の定量方法
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AU4248193A (en) 1992-05-15 1993-12-13 New England Deaconess Hospital Quantitation of viral rna by competitive polymerase chain reaction
EP0586112A3 (en) * 1992-08-14 1994-09-14 Pharma Gen S A Control of pcr mediated detection of micro-organisms
DE69332852T2 (de) * 1992-09-11 2003-12-04 Hoffmann La Roche Nachweis von Nukleinsäuren im Blut
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids

Also Published As

Publication number Publication date
EP0769954B1 (de) 2003-07-30
DK0769954T4 (da) 2011-04-04
ATE245989T1 (de) 2003-08-15
NO970050D0 (no) 1997-01-07
JPH10502943A (ja) 1998-03-17
EP0769954A1 (de) 1997-05-02
WO1996035437A1 (de) 1996-11-14
ES2203688T3 (es) 2004-04-16
EP0769954B2 (de) 2011-03-09
CA2191475A1 (en) 1996-11-14
NO322186B1 (no) 2006-08-28
AT406019B (de) 2000-01-25
JP2008247913A (ja) 2008-10-16
ES2203688T5 (es) 2011-07-01
DK0769954T3 (da) 2003-11-17
ATA77895A (de) 1999-06-15
DE59610626D1 (de) 2003-09-04
CA2191475C (en) 2010-09-14
NO970050L (no) 1997-01-07
IL118188A0 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
HUP9900822A3 (en) Piperazine derivatives, process for producing them, pharmaceutical compositions containing them and method for treating tachykinin-mediated diseases
AU6635990A (en) Process involving sterilization step, product having bacteriocidal activity and process for preparing the same, fumigant, fumigation method, and bacteriocidal gas composition, and process and apparatus for preparing the same
ZA966751B (en) Novel acyl derivatives of melatonin and of metalotoninergic analogues; process for their preparation and their use as medicinal products.
HUP9602511A3 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HU9402238D0 (en) 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
IL118188A (en) Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug
EP0378208A3 (en) Production method for protein-containing composition
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
NO971323L (no) Framgangsmåte for framstilling av stivelsesnedbrytningsprodukt
HUT50775A (en) Process for producing disubstituted pyridine derivatives and pharmaceutical compositions containing them as active components
HUP9602640A3 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
HUP9900105A3 (en) Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them
EE9600109A (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
UA29395C2 (uk) Похідне прегна-4,9(11),17(20)-трієн-3-она, спосіб його одержання, спосіб одержання 21-ацилоксипрегна-4, 9(11),16-трієн-3,20-діону та проміжні сполуки
PL247581A1 (en) Process for preparing novel derivatives of /4-ketoisolydinylideno-2-/acetamide
HUT58282A (en) Process for producing new, cyclic ketone derivatives and pharmaceutical compositions containing them as active components
HUT64548A (en) Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them
HU9401914D0 (en) Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both
GR3031544T3 (en) New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
HU9300306D0 (en) Method for producing indole derivatives
HU9500939D0 (en) New benzimidazol-2-yl derivatives, process for producing them and pharmaceutical compositions containing them
JO1822B1 (en) A new form of a compound

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired